Literature DB >> 30216810

Montreal Cognitive Assessment score correlates with regional cerebral blood flow in post-stroke patients.

Yuriko Nakaoku1, Naoya Oishi2, Yoshiki Hase3, Mai Hase3, Satoshi Saito4, Takahiro Mitsueda5, Masaru Matsui5, Kazunori Toyoda6, Kazuyuki Nagatsuka4, Raj N Kalaria3, Hidenao Fukuyama2, Masafumi Ihara7, Ryosuke Takahashi8.   

Abstract

OBJECTIVE: Valid and reliable measures are needed to assess post-stroke cognitive impairment. The Montreal Cognitive Assessment (MoCA) has been considered a superior screening test to the Mini-Mental State Examination (MMSE) for patients with post-stroke cognitive impairment, particularly in executive function, which may be related to reduction in regional cerebral blood flow (rCBF). In this study, we determined whether MoCA and MMSE scores correlate with rCBF assessed with SPECT in the subacute phase after ischemic stroke. PATIENTS AND METHODS: We retrospectively enrolled 28 patients who were admitted to the Red Cross Otsu Hospital with acute cerebral infarction, which was confirmed by magnetic resonance imaging (MRI), if they underwent cognitive assessment (MoCA/MMSE) and 123I-IMP SPECT imaging within 3 weeks post-stroke during a study period of 5 months. Correlation analyses between rCBF and MoCA or MMSE scores were performed by statistical parametric mapping (SPM) and volume-of-interest (VOI) analyses.
RESULTS: Total MoCA score correlated with the rCBF in the prefrontal cortex, cingulate cortex, caudate nucleus and thalamus by SPM analysis (uncorrected p < 0.001; cluster-level corrected p < 0.05). Among the subtest scores of MoCA, visuoexecutive function, attention, language and delayed recall scores were positively correlated with rCBF in the prefrontal cortex by VOI analysis (p < 0.05). However, total MMSE score did not correlate significantly with any of the rCBF measures.
CONCLUSIONS: Post-stroke cognitive performance assessed with MoCA positively correlated with rCBF in brain regions mainly comprising the prefrontal-subcortical circuits. The findings of this hypothesis-generating study support the notion that MoCA is useful for assessing post-stroke cognitive status.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebral blood flow; Montreal Cognitive Assessment; Post-stroke cognitive impairment; Prefrontal-subcortical circuits; SPECT; Statistical parametric mapping

Mesh:

Year:  2018        PMID: 30216810     DOI: 10.1016/j.clineuro.2018.09.004

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Microstructural damage of normal-appearing white matter in subcortical ischemic vascular dementia is associated with Montreal Cognitive Assessment scores.

Authors:  Zhangyuan Liao; Chun Dang; Meijie Li; Yali Bu; Ranran Han; Wei Jiang
Journal:  J Int Med Res       Date:  2019-07-25       Impact factor: 1.671

2.  Blood pressure variability is related to faster cognitive decline in ischemic stroke patients: PICASSO subanalysis.

Authors:  Ju-Hun Lee; Sun U Kwon; Yerim Kim; Jae-Sung Lim; Mi Sun Oh; Kyung-Ho Yu; Ji Sung Lee; Jong-Ho Park; Yong-Jae Kim; Joung-Ho Rha; Yang-Ha Hwang; Sung Hyuk Heo; Seong Hwan Ahn
Journal:  Sci Rep       Date:  2021-03-03       Impact factor: 4.379

3.  A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan.

Authors:  Kazuo Washida; Erika Kitajima; Tomotaka Tanaka; Shuhei Ikeda; Tetsuya Chiba; Kotaro Noda; Takeshi Yoshimoto; Kazuki Fukuma; Satoshi Saito; Masafumi Ihara
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  Structural disconnectome mapping of cognitive function in poststroke patients.

Authors:  Knut K Kolskår; Kristine M Ulrichsen; Genevieve Richard; Erlend S Dørum; Michel Thiebaut de Schotten; Jaroslav Rokicki; Jennifer Monereo-Sánchez; Andreas Engvig; Hege Ihle Hansen; Jan Egil Nordvik; Lars T Westlye; Dag Alnaes
Journal:  Brain Behav       Date:  2022-07-21       Impact factor: 3.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.